IL-12 is Required for Natural Killer Cell Activation and Subsequent T Helper 1 Cell Development in Experimental Leishmaniasis
Overview
Affiliations
Infection of mice with the protozoan Leishmania major is an established in vivo model for the definition of factors that contribute to CD4+ T helper cell subset development. In the current study, a central role for IL-12 in directing both the innate and adaptive immune responses to L. major is established. We show that in vivo neutralization of IL-12 eliminates the NK cell cytotoxic response and IFN-gamma production by lymph node cells from 2-day L. major-infected C3H mice. Moreover, anti-IL-12 treatment abrogated Th1 cell development and enhanced Th2 cell development. Consistent with these results, elevated IL-12 p40 production and an increase in the number of IL-12 p40-producing cells were observed within 1 day of infection in C3H mice. Because BALB/c mice lack an early NK cell response or a Th1-type immune response after L. major infection, we investigated the possibility that they had a defect in the ability to produce IL-12. Surprisingly, L. major infection stimulated IL-12 p40 production in BALB/c mice early after infection. Further studies suggest that BALB/c mice are unable to generate an early IFN-gamma response because of the simultaneous production of IL-12 and cytokines that inhibit IL-12 function, such as TGF-beta, IL-4, and IL-10. Together, these data show that IL-12 regulates the immune response to L. major, but that even when IL-12 is induced, Th1 cell development may be interrupted by simultaneous production of inhibitory cytokines.
-the struggles and battles of innate-like effector T lymphocytes with microbes.
Joyce S, Okoye G, Driver J Front Immunol. 2023; 14:1117825.
PMID: 37168859 PMC: 10165076. DOI: 10.3389/fimmu.2023.1117825.
Seo S, Jeong J, Baek B, Choi J, Choi Y, Ko H Front Immunol. 2021; 12:697162.
PMID: 34484196 PMC: 8416411. DOI: 10.3389/fimmu.2021.697162.
Potential biomarkers of immune protection in human leishmaniasis.
Nateghi Rostami M, Khamesipour A Med Microbiol Immunol. 2021; 210(2-3):81-100.
PMID: 33934238 PMC: 8088758. DOI: 10.1007/s00430-021-00703-8.
Host-Directed Therapies for Cutaneous Leishmaniasis.
Novais F, Farias Amorim C, Scott P Front Immunol. 2021; 12:660183.
PMID: 33841444 PMC: 8032888. DOI: 10.3389/fimmu.2021.660183.
Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.
Lim H, Jeffrey G, Ramm G, Soekmadji C Front Cell Infect Microbiol. 2020; 10:587628.
PMID: 33240824 PMC: 7683521. DOI: 10.3389/fcimb.2020.587628.